ADA 2017: Oral Agents Under Review

When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.

During the general poster sessions at the American Diabetes Association (ADA) 77th Scientific Sessions, several of the work-horse oral antihyperglycemic agents were highlighted in studies that looked at B12 deficiency with metformin therapy; adherence with different glimepiride regimens as assessed by an electronic monitoring system; and, the efficacy of a fixed-dose combination vs that of the individual components.